Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Morling Financial Advisors LLC

Morling Financial Advisors LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 660 shares of the medical equipment provider’s stock after buying an additional 40 shares during the period. Morling Financial Advisors LLC’s holdings in Intuitive Surgical were worth $344,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $31,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $33,000. Finally, Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $482.61 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a market cap of $171.90 billion, a price-to-earnings ratio of 75.29, a PEG ratio of 5.85 and a beta of 1.43. The stock’s 50-day simple moving average is $570.48 and its 200-day simple moving average is $531.79.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,309 shares of company stock valued at $7,611,004 over the last three months. 0.90% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms recently weighed in on ISRG. CICC Research began coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. Citigroup upped their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Truist Financial upped their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, Royal Bank of Canada increased their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.